ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients outcome

Ting Li, Yun Su, Yuping Mei, Qixin Leng, Bingjie Leng, Zhenqiu Liu, Sanford A. Stass, Feng Jiang

Research output: Contribution to journalArticle

225 Citations (Scopus)

Abstract

Prostate cancer (PCa) contains a small population of cancer stem cells (CSCs) that contribute to its initiation and progression. The development of specific markers for identification of the CSCs may lead to new diagnostic strategies of PCa. Increased aldehyde dehydrogenase 1A1 (ALDH1A1) activity has been found in the stem cell populations of leukemia and some solid tumors. The aim of the study was to investigate the stem-cell-related function and clinical significance of the ALDH1A1 in human PCa. ALDEFLUOR assay was used to isolate ALDH1A1 cells from PCa cell lines. Stem cell characteristics of the ALDH1A1 cells were then investigated by in vitro and in vivo approaches. The ALDH1A1 expression was also analyzed by immunohistochemistry in 18 normal prostate and 163 PCa tissues. The ALDH1A1 PCa cells showed high clonogenic and tumorigenic capacities, and serially reinitiated transplantable tumors that resembled histopathologic characteristics and heterogeneity of the parental PCa cells in mice. Immunohistochemical analysis of human prostate tissues showed that ALDH1A1 cells were sparse and limited to the basal component in normal prostates. However, in tumor specimens, increased ALDH1A1 immunopositivity was found not only in secretory type cancer epithelial cells but also in neuroendocrine tumor populations. Furthermore, the high ALDH1A1 expression in PCa was positively correlated with Gleason score (P0.01) and pathologic stage (P0.01), and inversely associated with overall survival and cancer-specific survival of the patients (P0.00093 and 0.00017, respectively). ALDH1A1 could be a prostate CSC-related marker. Measuring its expression might provide a potential approach to study tumorigenesis of PCa and predict outcome of the disease.

Original languageEnglish (US)
Pages (from-to)234-244
Number of pages11
JournalLaboratory Investigation
Volume90
Issue number2
DOIs
StatePublished - Feb 1 2010

Fingerprint

Aldehyde Dehydrogenase
Prostate
Prostatic Neoplasms
Stem Cells
Neoplastic Stem Cells
Neoplasms
Population
Survival
Neuroendocrine Tumors
Neoplasm Grading
Carcinogenesis
Leukemia
Epithelial Cells
Immunohistochemistry
Cell Line

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Li, Ting ; Su, Yun ; Mei, Yuping ; Leng, Qixin ; Leng, Bingjie ; Liu, Zhenqiu ; Stass, Sanford A. ; Jiang, Feng. / ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients outcome. In: Laboratory Investigation. 2010 ; Vol. 90, No. 2. pp. 234-244.
@article{37b5ad03db73487894d209382e3bb60f,
title = "ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients outcome",
abstract = "Prostate cancer (PCa) contains a small population of cancer stem cells (CSCs) that contribute to its initiation and progression. The development of specific markers for identification of the CSCs may lead to new diagnostic strategies of PCa. Increased aldehyde dehydrogenase 1A1 (ALDH1A1) activity has been found in the stem cell populations of leukemia and some solid tumors. The aim of the study was to investigate the stem-cell-related function and clinical significance of the ALDH1A1 in human PCa. ALDEFLUOR assay was used to isolate ALDH1A1 cells from PCa cell lines. Stem cell characteristics of the ALDH1A1 cells were then investigated by in vitro and in vivo approaches. The ALDH1A1 expression was also analyzed by immunohistochemistry in 18 normal prostate and 163 PCa tissues. The ALDH1A1 PCa cells showed high clonogenic and tumorigenic capacities, and serially reinitiated transplantable tumors that resembled histopathologic characteristics and heterogeneity of the parental PCa cells in mice. Immunohistochemical analysis of human prostate tissues showed that ALDH1A1 cells were sparse and limited to the basal component in normal prostates. However, in tumor specimens, increased ALDH1A1 immunopositivity was found not only in secretory type cancer epithelial cells but also in neuroendocrine tumor populations. Furthermore, the high ALDH1A1 expression in PCa was positively correlated with Gleason score (P0.01) and pathologic stage (P0.01), and inversely associated with overall survival and cancer-specific survival of the patients (P0.00093 and 0.00017, respectively). ALDH1A1 could be a prostate CSC-related marker. Measuring its expression might provide a potential approach to study tumorigenesis of PCa and predict outcome of the disease.",
author = "Ting Li and Yun Su and Yuping Mei and Qixin Leng and Bingjie Leng and Zhenqiu Liu and Stass, {Sanford A.} and Feng Jiang",
year = "2010",
month = "2",
day = "1",
doi = "10.1038/labinvest.2009.127",
language = "English (US)",
volume = "90",
pages = "234--244",
journal = "Laboratory Investigation",
issn = "0023-6837",
publisher = "Nature Publishing Group",
number = "2",

}

ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients outcome. / Li, Ting; Su, Yun; Mei, Yuping; Leng, Qixin; Leng, Bingjie; Liu, Zhenqiu; Stass, Sanford A.; Jiang, Feng.

In: Laboratory Investigation, Vol. 90, No. 2, 01.02.2010, p. 234-244.

Research output: Contribution to journalArticle

TY - JOUR

T1 - ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients outcome

AU - Li, Ting

AU - Su, Yun

AU - Mei, Yuping

AU - Leng, Qixin

AU - Leng, Bingjie

AU - Liu, Zhenqiu

AU - Stass, Sanford A.

AU - Jiang, Feng

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Prostate cancer (PCa) contains a small population of cancer stem cells (CSCs) that contribute to its initiation and progression. The development of specific markers for identification of the CSCs may lead to new diagnostic strategies of PCa. Increased aldehyde dehydrogenase 1A1 (ALDH1A1) activity has been found in the stem cell populations of leukemia and some solid tumors. The aim of the study was to investigate the stem-cell-related function and clinical significance of the ALDH1A1 in human PCa. ALDEFLUOR assay was used to isolate ALDH1A1 cells from PCa cell lines. Stem cell characteristics of the ALDH1A1 cells were then investigated by in vitro and in vivo approaches. The ALDH1A1 expression was also analyzed by immunohistochemistry in 18 normal prostate and 163 PCa tissues. The ALDH1A1 PCa cells showed high clonogenic and tumorigenic capacities, and serially reinitiated transplantable tumors that resembled histopathologic characteristics and heterogeneity of the parental PCa cells in mice. Immunohistochemical analysis of human prostate tissues showed that ALDH1A1 cells were sparse and limited to the basal component in normal prostates. However, in tumor specimens, increased ALDH1A1 immunopositivity was found not only in secretory type cancer epithelial cells but also in neuroendocrine tumor populations. Furthermore, the high ALDH1A1 expression in PCa was positively correlated with Gleason score (P0.01) and pathologic stage (P0.01), and inversely associated with overall survival and cancer-specific survival of the patients (P0.00093 and 0.00017, respectively). ALDH1A1 could be a prostate CSC-related marker. Measuring its expression might provide a potential approach to study tumorigenesis of PCa and predict outcome of the disease.

AB - Prostate cancer (PCa) contains a small population of cancer stem cells (CSCs) that contribute to its initiation and progression. The development of specific markers for identification of the CSCs may lead to new diagnostic strategies of PCa. Increased aldehyde dehydrogenase 1A1 (ALDH1A1) activity has been found in the stem cell populations of leukemia and some solid tumors. The aim of the study was to investigate the stem-cell-related function and clinical significance of the ALDH1A1 in human PCa. ALDEFLUOR assay was used to isolate ALDH1A1 cells from PCa cell lines. Stem cell characteristics of the ALDH1A1 cells were then investigated by in vitro and in vivo approaches. The ALDH1A1 expression was also analyzed by immunohistochemistry in 18 normal prostate and 163 PCa tissues. The ALDH1A1 PCa cells showed high clonogenic and tumorigenic capacities, and serially reinitiated transplantable tumors that resembled histopathologic characteristics and heterogeneity of the parental PCa cells in mice. Immunohistochemical analysis of human prostate tissues showed that ALDH1A1 cells were sparse and limited to the basal component in normal prostates. However, in tumor specimens, increased ALDH1A1 immunopositivity was found not only in secretory type cancer epithelial cells but also in neuroendocrine tumor populations. Furthermore, the high ALDH1A1 expression in PCa was positively correlated with Gleason score (P0.01) and pathologic stage (P0.01), and inversely associated with overall survival and cancer-specific survival of the patients (P0.00093 and 0.00017, respectively). ALDH1A1 could be a prostate CSC-related marker. Measuring its expression might provide a potential approach to study tumorigenesis of PCa and predict outcome of the disease.

UR - http://www.scopus.com/inward/record.url?scp=75949101677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75949101677&partnerID=8YFLogxK

U2 - 10.1038/labinvest.2009.127

DO - 10.1038/labinvest.2009.127

M3 - Article

C2 - 20010854

AN - SCOPUS:75949101677

VL - 90

SP - 234

EP - 244

JO - Laboratory Investigation

JF - Laboratory Investigation

SN - 0023-6837

IS - 2

ER -